GLAXF
Price
$18.73
Change
-$0.29 (-1.52%)
Updated
Jul 3 closing price
Capitalization
103.73B
ORINY
Price
$37.18
Change
+$0.09 (+0.24%)
Updated
Jun 26 closing price
Capitalization
5.42B
Interact to see
Advertisement

GLAXF vs ORINY

Header iconGLAXF vs ORINY Comparison
Open Charts GLAXF vs ORINYBanner chart's image
GSK
Price$18.73
Change-$0.29 (-1.52%)
Volume$265
Capitalization103.73B
Orion Corporation OY
Price$37.18
Change+$0.09 (+0.24%)
Volume$136
Capitalization5.42B
GLAXF vs ORINY Comparison Chart in %
Loading...
GLAXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORINY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLAXF vs. ORINY commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLAXF is a Hold and ORINY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (GLAXF: $18.73 vs. ORINY: $37.18)
Brand notoriety: GLAXF and ORINY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: GLAXF: 20% vs. ORINY: 60%
Market capitalization -- GLAXF: $103.73B vs. ORINY: $5.42B
GLAXF [@Pharmaceuticals: Major] is valued at $103.73B. ORINY’s [@Pharmaceuticals: Major] market capitalization is $5.42B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLAXF’s FA Score shows that 2 FA rating(s) are green whileORINY’s FA Score has 3 green FA rating(s).

  • GLAXF’s FA Score: 2 green, 3 red.
  • ORINY’s FA Score: 3 green, 2 red.
According to our system of comparison, ORINY is a better buy in the long-term than GLAXF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLAXF’s TA Score shows that 4 TA indicator(s) are bullish while ORINY’s TA Score has 1 bullish TA indicator(s).

  • GLAXF’s TA Score: 4 bullish, 4 bearish.
  • ORINY’s TA Score: 1 bullish, 3 bearish.
According to our system of comparison, GLAXF is a better buy in the short-term than ORINY.

Price Growth

GLAXF (@Pharmaceuticals: Major) experienced а +0.49% price change this week, while ORINY (@Pharmaceuticals: Major) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.13%. For the same industry, the average monthly price growth was +2.56%, and the average quarterly price growth was +9.33%.

Reported Earning Dates

ORINY is expected to report earnings on Apr 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+1.13% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLAXF($104B) has a higher market cap than ORINY($5.42B). GLAXF (17.36) and ORINY (17.06) have similar P/E ratio . ORINY YTD gains are higher at: 71.949 vs. GLAXF (11.314). GLAXF has higher annual earnings (EBITDA): 10B vs. ORINY (390M). GLAXF has more cash in the bank: 14B vs. ORINY (74.6M). ORINY has less debt than GLAXF: ORINY (207M) vs GLAXF (33.3B). GLAXF has higher revenues than ORINY: GLAXF (36.5B) vs ORINY (1.35B).
GLAXFORINYGLAXF / ORINY
Capitalization104B5.42B1,917%
EBITDA10B390M2,564%
Gain YTD11.31471.94916%
P/E Ratio17.3617.06102%
Revenue36.5B1.35B2,696%
Total Cash14B74.6M18,767%
Total Debt33.3B207M16,087%
FUNDAMENTALS RATINGS
GLAXF vs ORINY: Fundamental Ratings
GLAXF
ORINY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
29
Undervalued
PROFIT vs RISK RATING
1..100
10020
SMR RATING
1..100
4125
PRICE GROWTH RATING
1..100
6039
P/E GROWTH RATING
1..100
2660
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GLAXF's Valuation (9) in the null industry is in the same range as ORINY (29). This means that GLAXF’s stock grew similarly to ORINY’s over the last 12 months.

ORINY's Profit vs Risk Rating (20) in the null industry is significantly better than the same rating for GLAXF (100). This means that ORINY’s stock grew significantly faster than GLAXF’s over the last 12 months.

ORINY's SMR Rating (25) in the null industry is in the same range as GLAXF (41). This means that ORINY’s stock grew similarly to GLAXF’s over the last 12 months.

ORINY's Price Growth Rating (39) in the null industry is in the same range as GLAXF (60). This means that ORINY’s stock grew similarly to GLAXF’s over the last 12 months.

GLAXF's P/E Growth Rating (26) in the null industry is somewhat better than the same rating for ORINY (60). This means that GLAXF’s stock grew somewhat faster than ORINY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GLAXFORINY
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
37%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
42%
Momentum
ODDS (%)
Bearish Trend 3 days ago
58%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
63%
Bearish Trend 3 days ago
46%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
65%
Bullish Trend 3 days ago
28%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
57%
Bullish Trend 3 days ago
32%
Advances
ODDS (%)
Bullish Trend 4 days ago
65%
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
69%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
63%
Bullish Trend 3 days ago
31%
View a ticker or compare two or three
Interact to see
Advertisement
GLAXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORINY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WILC19.050.33
+1.76%
G Willi-Food International Ltd
NEUP7.130.11
+1.57%
Neuphoria Therapeutics Inc
HUBB414.84-0.28
-0.07%
Hubbell
HCC50.01-0.33
-0.66%
Warrior Met Coal
REPL9.40-0.15
-1.57%
Replimune Group

GLAXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLAXF has been loosely correlated with GSK. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if GLAXF jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLAXF
1D Price
Change %
GLAXF100%
-1.56%
GSK - GLAXF
37%
Loosely correlated
-0.86%
OPHLY - GLAXF
9%
Poorly correlated
-0.85%
HAWPF - GLAXF
8%
Poorly correlated
N/A
ORINY - GLAXF
6%
Poorly correlated
N/A
GIKLY - GLAXF
5%
Poorly correlated
N/A
More

ORINY and

Correlation & Price change

A.I.dvisor tells us that ORINY and GIKLY have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ORINY and GIKLY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORINY
1D Price
Change %
ORINY100%
N/A
GIKLY - ORINY
9%
Poorly correlated
N/A
GLAXF - ORINY
6%
Poorly correlated
-1.56%
NVSEF - ORINY
5%
Poorly correlated
-3.76%
OPHLY - ORINY
3%
Poorly correlated
-0.85%
MAYNF - ORINY
0%
Poorly correlated
N/A
More